Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Pervasip
(OTCPK:PVSP)
Intraday
$0.0003
0.0001
[16.67%]
Get Report
Watch
Perks
Buy
Compare Brokers
$0.0003
0.0001
[16.67%]
At close: May 17
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Pervasip Stock (OTC:PVSP)
Pervasip Stock (OTC: PVSP)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 24, 2024
Pervasip Reports Slight YoY Decrease In Q1 Revenue As It Prepares For Cannabis Spin-Off
Jelena Martinovic
-
Apr 24, 2024, 12:46PM
Friday, February 02, 2024
Pervasip Converts $15M Debt, Moves Toward Profitability With Cannabis Spin-Off
Jelena Martinovic
-
Feb 2, 2024, 1:38PM
Friday, June 30, 2023
Pervasip's Slurped Nano Cannabis Beverages Expanding Into California Market
Vuk Zdinjak
-
Jun 30, 2023, 10:09AM
Thursday, April 20, 2023
Pervasip To Enter Oregon Recreational Cannabis Market
Vuk Zdinjak
-
Apr 20, 2023, 10:48AM
Thursday, April 06, 2023
Pervasip Makes A 'Careful Step Into The World Of Industrial Quality Nano-Emulsification', Acquires Cannabis Tinctures Brand Slurped
Vuk Zdinjak
-
Apr 6, 2023, 8:33AM
Wednesday, March 01, 2023
Pervasip Reports 2022 Revenue Of $15.8M From Artizen Corporation
Vuk Zdinjak
-
Mar 1, 2023, 9:25AM
Wednesday, January 18, 2023
Pervasip Announces Artizen Spin Off
Vuk Zdinjak
-
Jan 18, 2023, 11:08AM
Tuesday, October 18, 2022
Pervasip Q3 Revenue Grows 17% Sequentially, Here Are The Details
Vuk Zdinjak
-
Oct 18, 2022, 11:02AM
Monday, October 10, 2022
Pervasip & Artizen Owners Announce New Acquisition & 4M In New Revenues
Jelena Martinovic
-
Oct 10, 2022, 10:13AM
Friday, May 13, 2022
Freedom Cannabis Forms Strategic Alliance With Artizen
Vuk Zdinjak
-
May 13, 2022, 3:54PM
Friday, December 27, 2019
Stocks That Hit 52-Week Lows On Friday
Lisa Levin
-
Dec 27, 2019, 11:40AM
Thursday, December 19, 2019
Stocks That Hit 52-Week Lows On Thursday
Lisa Levin
-
Dec 19, 2019, 11:02AM
